FeoB-family proteins are widely distributed in bacteria and archaea and are involved in high-affinity Fe 2+ uptake through the plasma membrane. FeoB consists of an N-terminal cytosolic region followed by a C-terminal transmembrane region. The cytosolic region contains small GTPase and GDP dissociation inhibitor-like domains, which serve a regulatory function. The truncated cytosolic region of the iron transporter FeoB from Thermotoga maritima was overexpressed, purified and crystallized. Four native or SeMet crystal forms in a nucleotide-free state or in complex with either GDP or GMPPNP diffracted to resolutions of between 1.5 and 2.1 Å .
Introduction
Iron is essential for the majority of life and participates in many major biological processes (Andrews et al., 2003) . Since both an excess and a deficiency of iron have negative effects, cellular iron homeostasis is critically important. The FeoB-family proteins are widely distributed integral membrane proteins in prokaryotes and are involved in the high-affinity Fe 2+ -uptake system (Kammler et al., 1993; Cartron et al., 2006) . In the pathogen Helicobacter pylori, FeoB is essential for the colonization of murine gastric mucosa and therefore provides the major pathway for Fe 2+ uptake (Velayudhan et al., 2000; Waidner et al., 2002) . While the driving force of the transport is still controversial, it has been suggested that FeoB functions as a transport ATPase because Fe 2+ uptake is inhibited by known ATPase inhibitors such as vanadate (Velayudhan et al., 2000) .
Escherichia coli FeoB (GenBank accession No. NP_417868) contains 773 residues and consists of an N-terminal cytosolic domain followed by a C-terminal transmembrane (TM) domain. The N-terminal region of the cytosolic domain has sequence homology to small GTPases, which are well known for their ubiquitous contribution to signal transduction in eukaryotes (Bourne et al., 1990) . In contrast, the contribution of bacterial small GTPases to bacterial regulatory pathways is largely unknown (Caldon & March, 2003) . The small GTPase domain (G domain) of FeoB hydrolyzes GTP slowly, but is required for Fe 2+ uptake and has therefore been proposed to serve a regulatory function (Marlovits et al., 2002) . Recently, it was revealed that the spacer region (residues 171-274) connecting the G (residues 1-170) and TM (residues 275-773) domains functions as a novel GDP dissociation inhibitor-like (GDI) domain that specifically stabilizes the GDP-binding state of the N-terminal G domain (Eng et al., 2008) . Although several structures of bacterial small GTPases have been reported (Chen et al., 1999; Buglino et al., 2002; Scrima et al., 2005) , there is no available structural homologue of the FeoB GDI domain. Thus, the mechanism of the GDI function of the FeoB cytosolic domain remains unclear. Here, we report the crystallization and preliminary crystallographic analysis of the truncated cytosolic domain of the iron transporter FeoB from Thermotoga maritima.
Methods and materials 2.1. Cloning, expression and purification
The domain boundary between the TM and cytosolic domains was predicted using the PSIPRED (McGuffin et al., 2000) , TOPPRED (von Heijne, 1992) and DISOPRED (Ward et al., 2004) programs. The truncated cytosolic domain of T. maritima FeoB (TmFeoB 17-269 ; M r = 28 655) was cloned from genomic DNA into the NdeI and BamHI sites of a pET-28a vector (Novagen, Wisconsin, USA) derivative including an N-terminal hexahistidine tag and a HRV 3C protease site. The recombinant protein was overexpressed in C41 (DE3) (Avidis, Saint-Beauzire, France) E. coli cells harbouring pRARE plasmids (Novagen, Wisconsin, USA) encoding rare codons grown in LB medium containing 50 mg ml À1 kanamycin at 310 K by induction at an OD 600 of $0.5 with 1 mM isopropyl -d-1thiogalactopyranoside (IPTG) for $16 h at 310 K. Selenomethionine-substituted (SeMet) protein was expressed in B834 (DH3) (Novagen, Wisconsin, USA) E. coli cells grown in Core medium (Wako, Osaka, Japan) with 50 mg ml À1 kanamycin and 25 mg ml À1 l-selenomethionine (Nakalai Tesque, Kyoto, Japan) by induction at an OD 600 of $0.5 with 1 mM IPTG for 20 h at 310 K. The truncated FeoB cytosolic domain contains five methionines per monomer.
All proteins were purified using the following procedure at 277 K. For all buffers, the pH given refers to that before the inclusion of all ingredients. The E. coli cells were disrupted by sonication using a Digital Sonifier (Branson, Connecticut, USA). After sonication in buffer A (50 mM Tris-HCl pH 8.0, 300 mM NaCl and 4 mM -mercaptoethanol) containing 1 mM PMSF and 20 mM imidazole, the disrupted cells were harvested by centrifugation (28 000g) for 40 min. T. maritima is an extremely thermophilic organism and its proteins are expected to be thermostable. Therefore, the cell lysate was agitated in a heat bath for 15 min at 343 K to remove E. coli proteins. After centrifugation (28 000g) for 40 min, the supernatant was loaded onto an Ni-NTA agarose column (Qiagen, California, USA) pre-equilibrated in buffer A containing 20 mM imidazole. The column-bound proteins were washed and eluted in buffer A containing 50 and 300 mM imidazole, respectively. The N-terminal His 6 tag of the eluted protein was cleaved by HRV3C protease (Takara Bio, Shiga, Japan) for $12 h at 310 K during dialysis against 50 mM Tris-HCl buffer pH 8.0 containing 50 mM NaCl and 4 mM -mercaptoethanol. The protease:target protein ratio was 1:100(w:w). This sample was again applied onto an Ni-NTA column preequilibrated with the buffer used for dialysis. The sample contained additional residues (Gly-Pro-Leu-His-Met) at the N-terminus after His-tag digestion. The flowthrough was fractionated and loaded onto a Resource Q 6 ml ion-exchange column (GE Healthcare, New Jersey, USA) pre-equilibrated with 50 mM Tris buffer pH 8.0 containing 50 mM NaCl and 1 mM DTT and the flowthrough was collected. Using an Amicon Ultra 10K filter (Millipore, Massachusetts, USA), the flowthrough was exchanged to 50 mM Tris-HCl buffer pH 8.0 containing 50 mM NaCl and 5 mM EDTA and concentrated. Further purification was carried out on a HiLoad 16/60 Superdex 200 120 ml (GE Healthcare, New Jersey, USA) gelfiltration column in 20 mM Tris-HCl buffer pH 8.0 containing 150 mM NaCl and 1 mM DTT. For crystallization trials, the purified protein was concentrated to approximately 10 mg ml À1 using an Amicon Ultra 10K filter. The yields of the purified native and SeMet TmFeoB 17-269 proteins were about 4 and 0.8 mg per litre of culture, respectively.
Crystallization
We used an IntelliPlate (Art Robbins, California, USA) for initial crystallization screening and a Cryschem plate (Hampton Research, California, USA) for optimization. For crystallization, purified protein solution (10 mg ml À1 ) was added to each reservoir solution. Initial screening for crystallization conditions was performed using Crystal Screen I, Crystal Screen II, Natrix, MembFac, Index Screen and SaltRX kits (Hampton Research, California, USA), JB Screen kits (Jena Bioscience, Jena, Germany) and MemSys and MemStart kits (Molecular Dimensions, Suffolk, England). A Hydra II Plus One crystallization robot (Matrix Technologies, New Hampshire, USA) was used for the initial crystallization screen, which used the sittingdrop vapour-diffusion method at 293 K. Crystallization drops prepared by mixing 0.2 ml protein solution and 0.2 ml reservoir solution were equilibrated against 100 ml reservoir solution. Prior to crystallization experiments, 500 mM MgCl 2 and either 100 mM GDP (Sigma, St Louis, USA) or 100 mM GMPPNP (GNPl Sigma, St Louis, USA) were optionally added to the protein solution. These solutions were added to the protein solution so that the final concentrations of MgCl 2 and nucleotides were 5 and 1 mM, respectively.
Native and SeMet crystals of TmFeoB 17-269 in the presence and absence of GDP or GMPPNP were first obtained in a week from condition No. 35 of Crystal Screen II (Hampton Research, California, USA). Further crystals in the presence of GDP were obtained under condition No. 73 of Index Screen (Hampton Research, California, USA). To optimize the crystallization conditions, crystallization drops prepared by mixing 1 ml protein solution and 1 ml reservoir solution were equilibrated against 500 ml reservoir solution. SeMet crystals in the presence of GDP were obtained under a condition containing 60-64% 2-methyl-2,4-pentanediol (MPD), 0.1 M HEPES pH 7.5 ( Fig. 1a ; crystal form A). Native crystals in the presence of GMPPNP were obtained under a condition containing 60-66% MPD, 0.1 M HEPES pH 7.5 and 4% 1,3-butanediol ( Fig. 1b; crystal form B) . Native crystals in the absence of GMPPNP or GDP were obtained under a condition containing 62-64% MPD and 0.1 M HEPES pH 7.5 ( Fig. 1c ; crystal form C). Native crystals in the presence of GDP were obtained under a condition containing 25% PEG 3350, 0.1 M Tris-HCl pH 8.5 and 0.1 M NaCl (Fig. 1d; crystal form D) . For observation of crystals, we used an Eclipse 50i POL (Nikon, Tokyo, Japan) without polarized light.
Preliminary crystallographic analysis
X-ray diffraction data sets were collected at 100 K under a cold nitrogen stream with an oscillation range per image of 1 using an ADSC Quantum 315 detector on beamline BL41XU at SPring-8 (Harima, Japan) or an ADSC Quantum 210 detector on beamline NW12 at Photon Factory (Tsukuba, Japan). All diffraction data sets were processed using the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997) and the CCP4 suite (Collaborative Computational Project, Number 4, 1994) . SeMet crystals of form A could be frozen directly in liquid nitrogen, while crystals of forms B, C and D were directly transferred into cryoprotectant solutions containing 40% MPD and 0.1 M HEPES pH 7.0, 5 mM MgCl 2 and 1 mM GMPPNP (form B), containing 40% MPD and 0.1 M HEPES pH 7.0 (form C) and containing 25%(w/v) PEG 3350, 0.1 M Tris-HCl pH 8.5, 0.1 M NaCl, 5 mM MgCl 2 , 1 mM GDP and 30% glycerol (form D). The Matthews coefficients and solvent contents were calculated using CCP4 (Collaborative Computational Project 4, Number 4, 1994) . The heavy-atom sites were identified using the program SHELXD (Sheldrick, 2008) .
Results and discussion
We first attempted to crystallize the entire TmFeoB cytosolic domain (residues 1-288). The domain boundary between the cytosolic (residues 1-286) and TM (residues 287-669) domains was predicted using the PSIPRED (McGuffin et al., 2000) and TOPPRED (von Heijne, 1992) programs. However, no well diffracting crystals were obtained in the presence or the absence of nucleotides. The N-terminal and C-terminal regions of the cytosolic domain (1-288) were predicted to be disordered by DISOPRED (Ward et al., 2004) . Thus, we attempted the crystallization of a truncated region (17-269) of the TmFeoB cytosolic domain. As a result, we successfully obtained well diffracting crystals of the TmFeoB cytosolic domain in the presence and absence of nucleotides. We could not harvest crystals of forms B and C without reducing the MPD concentration. Using a harvest buffer containing over 60% MPD, the crystals were easily dissolved. The data-collection statistics are summarized in contained two molecules in the asymmetric unit, while crystal form D contained one molecule in the asymmetric unit.
The molecular weight of the truncated FeoB cytosolic domain estimated by gel filtration using gel-filtration standards (Bio-Rad, California, USA) was 38 kDa, which is significantly lower than the molecular mass of the dimer (58 kDa; data not shown). Therefore, the FeoB cytosolic domain is most likely to be a monomer in solution. We have already identified ten selenium sites using the program SHELXD (Sheldrick, 2008) . The number of selenium sites is equivalent to that for two TmFeoB 17-269 molecules, which is reasonably consistent with the Matthews coefficient of crystal form A. Structure determination is in progress.
